← All trials
NCT06568094
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 6, 2024
- Primary completion
- Sep 1, 2025
- Completion date
- Dec 31, 2026
- First posted
- Aug 23, 2024
- Last posted
- Oct 23, 2024
- Enrollment
- 100
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hengrui Therapeutics, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.